65338-95-6

Upstream product

• 2162-31-4 2-(tetrahydropyran-2-yloxy)ethanol 
• 98-59-9 p-toluenesulfonyl chloride 
• 110-87-2 3,4-dihydro-2H-pyran 

Downstream Products

• 106658-66-6 C₂₄H₃₈O₈ 
• 72358-83-9 N,N-bis<2-(2-hydroxyethoxy)ethyl>-4-methylbenzenesulfonamide 
• 104128-75-8 (+)-(1R,2R,3S,4S)-2-benzyloxy-3-(2-hydroxyethoxy)-1,7,7-trimethylbicyclo<2.2.1>heptane 
• 150125-90-9 N,N-bis<(R)-1-(2-hydroxyethoxy)-1-phenylethan-2-yl>-p-toluenesulfonamide 
• 78502-20-2 Z-α,β-(2-hydroxyethoxy-)-stilbene 
• 78502-17-7 E-α,β-(2-hydroxyethoxy-)-stilbene 
• 104128-83-8 (-)-(1R,2S,3R,4S)-2-(2-tetrahydropyranyloxy)ethoxy-3-(2-benzyloxy)ethoxy-1,7,7-trimethylbicyclo<2.2.1>heptane 
• 104128-84-9 (1R,2S,3R,4S)-2-(2-tetrahydropyranyloxy)ethoxy-3-(2-tosyloxy)ethoxy-1,7,7-trimethylbicyclo<2.2.1>heptane 
• 1235382-40-7 benzyl 4-[2-(tetrahydro-2H-pyran-2-yloxy)ethoxy]piperidine-1-carboxylate 

Relevant academic research and scientific papers

DIAGNOSTIC AGENT FOR THERAPEUTIC EFFECT ON CANCER

The present invention provides a diagnostic agent for a therapeutic effect on cancer, containing a compound represented by formula (1-0). (In formula (1-0), R represents —O(CH2)n—, —O(CH2)nOC2H4—, —CH2O(CH2)n—, or —CH2O(CH2)nOC2H4—, n represents an integer of 1 to 5, and Q1 represents F or —OCH3.)

POLYMERIC MATERIALS

The present invention relates to a polymer comprising as part of its polymer backbone a moiety of Formula (II): where one of R6 to R10 represents A-O— and one of R6 to R10 represents —O—B and the remainder of R6 to R10 represent H, where A and B represent the remainder of the polymer backbone and may be the same or different.

COMPOUND SUITABLE FOR DETECTION OF MITOCHONDRIAL COMPLEX-1

Provided is a compound represented by formula (1-0): wherein in formula (1-0), R represents —O(CH2)n—, —O(CH2)nOC2H4—, —CH2O(CH2)n— or —CH2O(CHs

Synthesis of Chiral Diaza-18-crown-6 Derivatives from Optically Active Diethanolamines

Homotopic 1,10-diaza-18-crown-6 derivatives with two, four, and six chiral centers have been prepared in optically active form from diethanolamines via a cyclization reaction with tosylates 39 and 48.The requisite optically active diethanolamines were prepared from chiral cyanohydrins and chiral ethanolamines by a one-pot Grignard-transimination-reduction or a one-pot reduction-transimination-reduction procedure.Yields were strongly affected by the size of the substituents α to the nitrogen atom.The stereoselectivity of the diethanolamine synthesis was found to depend on the configuration of the ethanolamine used.

Neutral Ligands with Surfactant-Type Structure - Synthesis, Complexation, and Ion Transfer

New lipophilic neutral ligands which combine crown ether and podand characteristics with structural features of surfactants (cf. formulas 1-12, 16-26) were synthesized.Their complexation behaviour was studied, their solid-to-liquid and liquid-to-liquid phase transfer properties as well as their efficiency in ion transport across a liquid model membrane.Crystalline stoichiometric complexes of the cycles 2a-4a and of 3e with NaSCN, Ba(SCN)2, and BaI2 can be isolated.Among the noncyclic representatives a crystalline complex is obtained only from 11 with BaI2.The ligand 8d behaves in aqueous solution as a typical surfactant showing micelle formation and cloud point.